AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (451.4 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers

Juanjuan Feng1,2,*Xuanzheng Xiao3,*Zhengke Lian1Ao Zhang3Xiufeng Pang1,4 ( )
Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China
Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an 710061, China
Shanghai Frontiers Science Center for Drug Target Identification and Delivery, State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China
Chongqing Institute of East China Normal University, Chongqing 401120, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 162-168

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Feng J, Xiao X, Lian Z, et al. Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers. Cancer Biology & Medicine, 2026, 23(2): 162-168. https://doi.org/10.20892/j.issn.2095-3941.2025.0612

622

Views

68

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 08 October 2025
Accepted: 05 January 2026
Published: 09 February 2026
©2026 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)